Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Gross Margin (2020 - 2025)

Historic Gross Margin for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to 66.32%.

  • SOPHiA GENETICS's Gross Margin fell 8900.0% to 66.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 67.52%, marking a year-over-year decrease of 3000.0%. This contributed to the annual value of 67.42% for FY2024, which is 13900.0% down from last year.
  • SOPHiA GENETICS's Gross Margin amounted to 66.32% in Q3 2025, which was down 8900.0% from 66.97% recorded in Q2 2025.
  • Over the past 5 years, SOPHiA GENETICS's Gross Margin peaked at 61210453.92% during Q2 2021, and registered a low of 62.45% during Q4 2021.
  • Over the past 5 years, SOPHiA GENETICS's median Gross Margin value was 66.97% (recorded in 2025), while the average stood at 3221665.91%.
  • As far as peak fluctuations go, SOPHiA GENETICS's Gross Margin skyrocketed by 2000000000bps in 2021, and later plummeted by 2000000000bps in 2022.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Gross Margin stood at 62.45% in 2021, then increased by 15bps to 71.96% in 2022, then dropped by -3bps to 69.79% in 2023, then decreased by -2bps to 68.25% in 2024, then decreased by -3bps to 66.32% in 2025.
  • Its Gross Margin stands at 66.32% for Q3 2025, versus 66.97% for Q2 2025 and 68.67% for Q1 2025.